US 11072581
N-acyl-arylsulfonamide derivatives as aminoacyl-tRNA synthetase inhibitors
granted A61PA61P1/00A61P1/02
Quick answer
US patent 11072581 (N-acyl-arylsulfonamide derivatives as aminoacyl-tRNA synthetase inhibitors) held by Oxford Drug Design Limited expires Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Oxford Drug Design Limited
- Grant date
- Tue Jul 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P1/00, A61P1/02, A61P11/00, A61P13/00